Cas Medical Systems (CASM) 1.36 $CASM
Nasdaq stocks posting largest volume increases
AP - Thu Feb 12, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
BLDP: 2.66 (-0.26), LARK: 22.50 (+0.15), BELFB: 23.44 (+0.60), BELFA: 19.90 (-0.40), CASM: 1.36 (-0.01), FXEN: 1.99 (+0.10), SOCB: 7.23 (+0.11), MKTO: 28.24 (+0.20), ATRA: 18.00 (-0.10), GEVO: 0.23 (+0.03), NWFL: 30.00 (+0.25), OCLR: 1.55 (+0.09)
CAS Medical Systems Announces Pricing of Public Offering of Common Stock
GlobeNewswire - Wed Feb 11, 9:55AM CST
CAS Medical Systems, Inc. ("CASMED" or the "Company"
(Nasdaq:CASM), a medical technology company that develops, manufactures and markets non-invasive patient monitoring products, today announced that it has priced a firm commitment underwritten public offering of 6,200,000 shares of its common stock at a price to the public of $1.30 per share. In addition, CASMED has granted the underwriter a 30-day option to purchase up to 930,000 additional shares of common stock to cover over-allotments, if any. The offering is expected to close on or about February 17, 2015, subject to satisfaction of closing conditions.
CASM: 1.36 (-0.01)
CAS Medical prices equity offering
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 7:36AM CST
CASM: 1.36 (-0.01)
CAS Medical Systems Announces Proposed Public Offering of Common Stock
GlobeNewswire - Wed Feb 04, 3:06PM CST
CAS Medical Systems, Inc. ("CASMED" or the "Company" (Nasdaq:CASM), a medical technology company that develops, manufactures and markets non-invasive patient monitoring products, today announced that it intends to offer $8.0 million worth of its common stock in an underwritten public offering, subject to market and other conditions. In addition, the Company intends to grant the underwriter an option to purchase additional shares equal to up to 15% of the aggregate number of shares to be sold in the offering. All of the shares in the offering will be sold by the Company.
CASM: 1.36 (-0.01)
CASMED Engages Deltex Medical as Exclusive FORE-SIGHT(R) Distributor for the United Kingdom and Ireland
GlobeNewswire - Mon Jan 12, 8:15AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the engagement of Deltex Medical Group plc (AIM
EMG) as the exclusive distributor of CASMED's FORE-SIGHT line of cerebral oximeter monitors for the United Kingdom and Ireland. The engagement of Deltex is effective as of January 1, 2015.
CASM: 1.36 (-0.01)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 11:47AM CST
ELOS: 10.16 (+0.07), MBII: 3.88 (+0.33), PDFS: 18.31 (+0.04), CASM: 1.36 (-0.01), PHMD: 1.68 (+0.04), EPRS: 7.67 (+0.67), BIND: 6.06 (+0.21), JOB: 0.79 (+0.01), STML: 14.07 (-0.10), BIOD: 1.38 (-0.14), ARO: 3.63 (+0.04), PODD: 32.00 (-0.07), AOI: 1.05 (+0.03), BWEN: 5.48 (+0.15), NBIX: 37.22 (+0.27), VLCCF: 4.15 (-0.06), NEFF: 10.43 (-0.04), PSTR: 4.63 (+0.14), INFI: 15.13 (+0.55), APOL: 25.97 (+0.33)
CAS Med reports preliminary results
Seeking Alpha - at Seeking Alpha - Wed Jan 07, 8:05AM CST
CASM: 1.36 (-0.01)
CASMED Reports Preliminary Sales for the 2014 Fourth Quarter and Full Year
GlobeNewswire - Wed Jan 07, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, reports preliminary unaudited top-line results for the fourth quarter and full year ended December 31, 2014.
CASM: 1.36 (-0.01)
InsiderInsights.com Daily Round Up 1/5/15: LTS, AXDX, VEEV, CAS
InsiderInsights - at Seeking Alpha - Tue Jan 06, 4:05AM CST
STFC: 23.46 (+0.15), LBTYK: 50.78 (+2.40), CASM: 1.36 (-0.01), IP: 57.31 (+0.12), VVUS: 2.68 (+0.13), STRN: 5.33 (-0.04), LTS: 3.92 (-0.02), WDC: 107.61 (+0.42), VEEV: 30.12 (+0.17), HLT: 28.57 (+0.13), LNKD: 269.00 (+1.83), AXDX: 22.86 (-0.33), ENSV: 2.23 (+0.04), CAS: 6.14 (-0.01), GPRE: 25.50 (-0.56), BLMN: 24.45 (-0.16), JGW: 10.70 (-0.16), CRM: 62.85 (+1.59)
CASMED Appoints Paul Molloy to Its Board of Directors
GlobeNewswire - Mon Jan 05, 7:26AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the appointment of Paul Molloy to the Company's Board of Directors. Mr. Molloy's appointment increases the size of the CASMED Board to six Directors.
CASM: 1.36 (-0.01), TFX: 112.07 (+0.47)
Global Pulse Oximeters Market
PR Newswire - Tue Dec 30, 1:12PM CST
This report analyzes the worldwide markets for Pulse Oximeters in US$ Thousands by the following Product Segments: Pulse Oximeter Monitors, and Sensors. The market for 'Pulse Oximeter Monitors' is analyzed by the following Product Types and End-Use Segments and covers non-invasive pulse oximeters only: Product Types: Stand-Alone Devices, (Bedside Devices, & Handheld Devices), and Multiparameter Units; End-Use Segments: Hospital Care (Stand-Alone, & Multiparameter), and Alternate Care (Stand-Alone, & Multiparameter). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 100 companies including many key and niche players such as -
CASM: 1.36 (-0.01)
Pulse Oximeters: Pulse Oximeter Monitors & Sensors - 2014 Global Strategic Business Report
M2 - Thu Dec 18, 4:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/5c6rrn/pulse_oximeters) has announced the addition of the "Pulse Oximeters - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Pulse Oximeters in US$ Thousands by the following Product Segments: - Pulse Oximeter Monitors - Sensors The market for 'Pulse Oximeter Monitors' is analyzed by the following Product Types and End-Use Segments and covers non-invasive pulse oximeters only: - Product Types: Stand-Alone Devices, (Bedside Devices, & Handheld Devices), and Multiparameter Units - End-Use Segments: Hospital Care (Stand-Alone, & Multiparameter), and Alternate Care (Stand-Alone, & Multiparameter). The report profiles 100 companies including many key and niche players such as: - CAS Medical Systems, Inc. - Covidien Plc - Masimo Corporation - Nihon-Kohden Corp. - Nonin Medical, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Dynamics 3. Market Trends & Issues 4. Application Overview 5. Competitive Landscape 6. Product Overview 7. Product Innovations/Introductions 8. Recent Industry Activity 9. Focus On Select Global Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 100 (including Divisions/Subsidiaries 112) - The United States (47) - Canada (1) - Japan (6) - Europe (22) - Germany (9) - The United Kingdom (5) - Italy (4) - Spain (1) - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (35) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5c..._oximeters
MASI: 27.38 (-0.21), CASM: 1.36 (-0.01)
Masimo's Radius-7 Monitor Gets FDA Nod, Rivalry Intensifies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 6:00PM CST
Manufacturer of patient monitoring products, Masimo Corp. (MASI) recently announced Food and Drug Administration (FDA)'s clearance of the company's Radius-7 wireless monitor.
BABY: 36.96 (-0.03), MASI: 27.38 (-0.21), CASM: 1.36 (-0.01), COV: 106.71 (-1.36)
CASMED to Present at the LD MICRO MAIN EVENT: VII Conference on December 2, 2014
GlobeNewswire - Tue Nov 18, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that Thomas M. Patton, President and Chief Executive Officer, will present at the seventh annual LD MICRO MAIN EVENT conference on Tuesday, December 2, 2014, at 11:00 a.m. Pacific time. The conference will be held at the Luxe Sunset Hotel in Los Angeles.
CASM: 1.36 (-0.01)
CAS Medical Systems' (CASM) CEO Tom Patton on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 10:04PM CST
CASM: 1.36 (-0.01)
CAS Medical Systems beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 6:07AM CST
CASM: 1.36 (-0.01)
CASMED Announces Third Quarter 2014 Financial Results
GlobeNewswire - Tue Nov 04, 6:01AM CST
FORE-SIGHT Sales Increase 55%, Operating Loss Narrows Substantially
CASM: 1.36 (-0.01)
CAS Medical reports November 4
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 11:10AM CDT
CASM: 1.36 (-0.01)
CASMED to Announce Third Quarter 2014 Financial Results and Hold Conference Call on November 4th
GlobeNewswire - Tue Oct 28, 7:00AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced it will report financial results for the third quarter of 2014 on Tuesday, November 4, 2014, prior to the market's opening. Management will host a conference call to discuss those results and answer questions beginning at 10:00 a.m. Eastern time that day.
CASM: 1.36 (-0.01)
CASMED to Participate in BTIG's Inaugural Emerging Technologies in Healthcare Diagnostics Symposium
GlobeNewswire - Thu Sep 25, 11:42AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that Thomas M. Patton, President and Chief Executive Officer, will be participating in BTIG's Inaugural Emerging Technologies in Healthcare Diagnostics Symposium, to be held September 29 and 30 in New York City.
CASM: 1.36 (-0.01)
Nasdaq stocks posting largest volume increases
AP - Thu Feb 12, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
BLDP: 2.66 (-0.26), LARK: 22.50 (+0.15), BELFB: 23.44 (+0.60), BELFA: 19.90 (-0.40), CASM: 1.36 (-0.01), FXEN: 1.99 (+0.10), SOCB: 7.23 (+0.11), MKTO: 28.24 (+0.20), ATRA: 18.00 (-0.10), GEVO: 0.23 (+0.03), NWFL: 30.00 (+0.25), OCLR: 1.55 (+0.09)
CAS Medical Systems Announces Pricing of Public Offering of Common Stock
GlobeNewswire - Wed Feb 11, 9:55AM CST
CAS Medical Systems, Inc. ("CASMED" or the "Company"
(Nasdaq:CASM), a medical technology company that develops, manufactures and markets non-invasive patient monitoring products, today announced that it has priced a firm commitment underwritten public offering of 6,200,000 shares of its common stock at a price to the public of $1.30 per share. In addition, CASMED has granted the underwriter a 30-day option to purchase up to 930,000 additional shares of common stock to cover over-allotments, if any. The offering is expected to close on or about February 17, 2015, subject to satisfaction of closing conditions. CASM: 1.36 (-0.01)
CAS Medical prices equity offering
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 7:36AM CST
CASM: 1.36 (-0.01)
CAS Medical Systems Announces Proposed Public Offering of Common Stock
GlobeNewswire - Wed Feb 04, 3:06PM CST
CAS Medical Systems, Inc. ("CASMED" or the "Company"
(Nasdaq:CASM), a medical technology company that develops, manufactures and markets non-invasive patient monitoring products, today announced that it intends to offer $8.0 million worth of its common stock in an underwritten public offering, subject to market and other conditions. In addition, the Company intends to grant the underwriter an option to purchase additional shares equal to up to 15% of the aggregate number of shares to be sold in the offering. All of the shares in the offering will be sold by the Company. CASM: 1.36 (-0.01)
CASMED Engages Deltex Medical as Exclusive FORE-SIGHT(R) Distributor for the United Kingdom and Ireland
GlobeNewswire - Mon Jan 12, 8:15AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the engagement of Deltex Medical Group plc (AIM
EMG) as the exclusive distributor of CASMED's FORE-SIGHT line of cerebral oximeter monitors for the United Kingdom and Ireland. The engagement of Deltex is effective as of January 1, 2015. CASM: 1.36 (-0.01)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 11:47AM CST
ELOS: 10.16 (+0.07), MBII: 3.88 (+0.33), PDFS: 18.31 (+0.04), CASM: 1.36 (-0.01), PHMD: 1.68 (+0.04), EPRS: 7.67 (+0.67), BIND: 6.06 (+0.21), JOB: 0.79 (+0.01), STML: 14.07 (-0.10), BIOD: 1.38 (-0.14), ARO: 3.63 (+0.04), PODD: 32.00 (-0.07), AOI: 1.05 (+0.03), BWEN: 5.48 (+0.15), NBIX: 37.22 (+0.27), VLCCF: 4.15 (-0.06), NEFF: 10.43 (-0.04), PSTR: 4.63 (+0.14), INFI: 15.13 (+0.55), APOL: 25.97 (+0.33)
CAS Med reports preliminary results
Seeking Alpha - at Seeking Alpha - Wed Jan 07, 8:05AM CST
CASM: 1.36 (-0.01)
CASMED Reports Preliminary Sales for the 2014 Fourth Quarter and Full Year
GlobeNewswire - Wed Jan 07, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, reports preliminary unaudited top-line results for the fourth quarter and full year ended December 31, 2014.
CASM: 1.36 (-0.01)
InsiderInsights.com Daily Round Up 1/5/15: LTS, AXDX, VEEV, CAS
InsiderInsights - at Seeking Alpha - Tue Jan 06, 4:05AM CST
STFC: 23.46 (+0.15), LBTYK: 50.78 (+2.40), CASM: 1.36 (-0.01), IP: 57.31 (+0.12), VVUS: 2.68 (+0.13), STRN: 5.33 (-0.04), LTS: 3.92 (-0.02), WDC: 107.61 (+0.42), VEEV: 30.12 (+0.17), HLT: 28.57 (+0.13), LNKD: 269.00 (+1.83), AXDX: 22.86 (-0.33), ENSV: 2.23 (+0.04), CAS: 6.14 (-0.01), GPRE: 25.50 (-0.56), BLMN: 24.45 (-0.16), JGW: 10.70 (-0.16), CRM: 62.85 (+1.59)
CASMED Appoints Paul Molloy to Its Board of Directors
GlobeNewswire - Mon Jan 05, 7:26AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces the appointment of Paul Molloy to the Company's Board of Directors. Mr. Molloy's appointment increases the size of the CASMED Board to six Directors.
CASM: 1.36 (-0.01), TFX: 112.07 (+0.47)
Global Pulse Oximeters Market
PR Newswire - Tue Dec 30, 1:12PM CST
This report analyzes the worldwide markets for Pulse Oximeters in US$ Thousands by the following Product Segments: Pulse Oximeter Monitors, and Sensors. The market for 'Pulse Oximeter Monitors' is analyzed by the following Product Types and End-Use Segments and covers non-invasive pulse oximeters only: Product Types: Stand-Alone Devices, (Bedside Devices, & Handheld Devices), and Multiparameter Units; End-Use Segments: Hospital Care (Stand-Alone, & Multiparameter), and Alternate Care (Stand-Alone, & Multiparameter). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 100 companies including many key and niche players such as -
CASM: 1.36 (-0.01)
Pulse Oximeters: Pulse Oximeter Monitors & Sensors - 2014 Global Strategic Business Report
M2 - Thu Dec 18, 4:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/5c6rrn/pulse_oximeters) has announced the addition of the "Pulse Oximeters - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Pulse Oximeters in US$ Thousands by the following Product Segments: - Pulse Oximeter Monitors - Sensors The market for 'Pulse Oximeter Monitors' is analyzed by the following Product Types and End-Use Segments and covers non-invasive pulse oximeters only: - Product Types: Stand-Alone Devices, (Bedside Devices, & Handheld Devices), and Multiparameter Units - End-Use Segments: Hospital Care (Stand-Alone, & Multiparameter), and Alternate Care (Stand-Alone, & Multiparameter). The report profiles 100 companies including many key and niche players such as: - CAS Medical Systems, Inc. - Covidien Plc - Masimo Corporation - Nihon-Kohden Corp. - Nonin Medical, Inc. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Dynamics 3. Market Trends & Issues 4. Application Overview 5. Competitive Landscape 6. Product Overview 7. Product Innovations/Introductions 8. Recent Industry Activity 9. Focus On Select Global Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 100 (including Divisions/Subsidiaries 112) - The United States (47) - Canada (1) - Japan (6) - Europe (22) - Germany (9) - The United Kingdom (5) - Italy (4) - Spain (1) - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (35) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5c..._oximeters
MASI: 27.38 (-0.21), CASM: 1.36 (-0.01)
Masimo's Radius-7 Monitor Gets FDA Nod, Rivalry Intensifies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 6:00PM CST
Manufacturer of patient monitoring products, Masimo Corp. (MASI) recently announced Food and Drug Administration (FDA)'s clearance of the company's Radius-7 wireless monitor.
BABY: 36.96 (-0.03), MASI: 27.38 (-0.21), CASM: 1.36 (-0.01), COV: 106.71 (-1.36)
CASMED to Present at the LD MICRO MAIN EVENT: VII Conference on December 2, 2014
GlobeNewswire - Tue Nov 18, 7:00AM CST
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that Thomas M. Patton, President and Chief Executive Officer, will present at the seventh annual LD MICRO MAIN EVENT conference on Tuesday, December 2, 2014, at 11:00 a.m. Pacific time. The conference will be held at the Luxe Sunset Hotel in Los Angeles.
CASM: 1.36 (-0.01)
CAS Medical Systems' (CASM) CEO Tom Patton on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 10:04PM CST
CASM: 1.36 (-0.01)
CAS Medical Systems beats by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 6:07AM CST
CASM: 1.36 (-0.01)
CASMED Announces Third Quarter 2014 Financial Results
GlobeNewswire - Tue Nov 04, 6:01AM CST
FORE-SIGHT Sales Increase 55%, Operating Loss Narrows Substantially
CASM: 1.36 (-0.01)
CAS Medical reports November 4
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 11:10AM CDT
CASM: 1.36 (-0.01)
CASMED to Announce Third Quarter 2014 Financial Results and Hold Conference Call on November 4th
GlobeNewswire - Tue Oct 28, 7:00AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced it will report financial results for the third quarter of 2014 on Tuesday, November 4, 2014, prior to the market's opening. Management will host a conference call to discuss those results and answer questions beginning at 10:00 a.m. Eastern time that day.
CASM: 1.36 (-0.01)
CASMED to Participate in BTIG's Inaugural Emerging Technologies in Healthcare Diagnostics Symposium
GlobeNewswire - Thu Sep 25, 11:42AM CDT
CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, today announced that Thomas M. Patton, President and Chief Executive Officer, will be participating in BTIG's Inaugural Emerging Technologies in Healthcare Diagnostics Symposium, to be held September 29 and 30 in New York City.
CASM: 1.36 (-0.01)
